Moore Capital Management LP Buys Shares of 38,929 Option Care Health, Inc. (NASDAQ:OPCH)

Moore Capital Management LP purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 38,929 shares of the company's stock, valued at approximately $903,000.

A number of other hedge funds have also added to or reduced their stakes in OPCH. Barclays PLC boosted its stake in Option Care Health by 180.1% during the 3rd quarter. Barclays PLC now owns 310,194 shares of the company's stock valued at $9,708,000 after purchasing an additional 199,454 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in Option Care Health by 128.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 292,090 shares of the company's stock valued at $6,776,000 after purchasing an additional 164,086 shares during the last quarter. Wedge Capital Management L L P NC acquired a new position in Option Care Health during the 4th quarter valued at about $3,245,000. Diversify Wealth Management LLC boosted its stake in Option Care Health by 31.7% during the 4th quarter. Diversify Wealth Management LLC now owns 13,560 shares of the company's stock valued at $325,000 after purchasing an additional 3,261 shares during the last quarter. Finally, UMB Bank n.a. boosted its stake in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Stock Performance

Option Care Health stock traded up $0.74 during trading on Friday, hitting $33.23. The stock had a trading volume of 1,396,952 shares, compared to its average volume of 1,856,304. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock's 50 day moving average is $33.07 and its two-hundred day moving average is $28.98. The stock has a market cap of $5.44 billion, a price-to-earnings ratio of 27.92, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the business earned $0.26 earnings per share. Option Care Health's revenue for the quarter was up 16.3% on a year-over-year basis. As a group, analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.64% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. JMP Securities restated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.